COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Authors
Keywords
-
Journal
Journal of Fungi
Volume 6, Issue 2, Pages 91
Publisher
MDPI AG
Online
2020-06-24
DOI
10.3390/jof6020091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination?
- (2020) Bart J A Rijnders et al. CLINICAL INFECTIOUS DISEASES
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 Associated Pulmonary Aspergillosis
- (2020) Andreas L.E. van Arkel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
- (2020) Yingzhen Du et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- IL‐1 blockade with anakinra in acute leukaemia patients with severe COVID‐19 pneumonia appears safe and may result in clinical improvement
- (2020) James W. Day et al. BRITISH JOURNAL OF HAEMATOLOGY
- Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
- (2020) Mihai G. Netea et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
- (2020) George Dimopoulos et al. Cell Host & Microbe
- A Dynamic Immune Response Shapes COVID-19 Progression
- (2020) Eugenia Ziying Ong et al. Cell Host & Microbe
- Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
- (2020) Timothy M Rawson et al. CLINICAL INFECTIOUS DISEASES
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 pandemic—a focused review for clinicians
- (2020) M. Cevik et al. CLINICAL MICROBIOLOGY AND INFECTION
- The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
- (2020) Tao Liu et al. EMBO Molecular Medicine
- Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis
- (2020) M. Bassetti et al. JOURNAL OF INFECTION
- COVID‐19 associated pulmonary aspergillosis
- (2020) Philipp Koehler et al. MYCOSES
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge
- (2020) Spinello Antinori et al. Travel Medicine and Infectious Disease
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- COVID-19-associated invasive pulmonary aspergillosis
- (2020) Lynn Rutsaert et al. Annals of Intensive Care
- Pulmonary fibrosis secondary to COVID-19: a call to arms?
- (2020) Paolo Spagnolo et al. Lancet Respiratory Medicine
- Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
- (2020) Alexandre Alanio et al. Lancet Respiratory Medicine
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
- (2020) T. Lahmer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
- (2020) Guqin Zhang et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical and virological data of the first cases of COVID-19 in Europe: a case series
- (2020) Francois-Xavier Lescure et al. LANCET INFECTIOUS DISEASES
- Co-infection with respiratory pathogens among COVID-2019 cases
- (2020) Xiaojuan Zhu et al. VIRUS RESEARCH
- Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
- (2020) George R Thompson III et al. Open Forum Infectious Diseases
- Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
- (2020) Eelco F. J. Meijer et al. Journal of Fungi
- Linking Tropical Infections to Hypertension: New Comorbid Disease Paradigms in Our Era of “Blue Marble Health”
- (2019) Peter J. Hotez Journal of the American Heart Association
- Diagnosis and treatment of invasive fungal infections: looking ahead
- (2019) Maurizio Sanguinetti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside
- (2019) Marion Aruanno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies
- (2019) Blake Nield et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies
- (2019) Marta Stanzani et al. JOURNAL OF INFECTION
- The Hidden Cost of Modern Medical Interventions: How Medical Advances Have Shaped the Prevalence of Human Fungal Disease
- (2019) Callum Clark et al. Pathogens
- New drugs target growing threat of fatal fungi
- (2019) Kai Kupferschmidt SCIENCE
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
- (2019) J Peter Donnelly et al. CLINICAL INFECTIOUS DISEASES
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species
- (2018) Nathan P Wiederhold et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
- (2018) Julia A. Critchley et al. DIABETES CARE
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
- (2018) Alexander F A D Schauwvlieghe et al. Lancet Respiratory Medicine
- Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
- (2018) Pieter P.A. Lestrade et al. CLINICAL MICROBIOLOGY AND INFECTION
- Improving the rates of Aspergillus detection: an update on current diagnostic strategies
- (2018) Jeffrey D. Jenks et al. Expert Review of Anti-Infective Therapy
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units.Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project
- (2018) M. Bassetti et al. MYCOSES
- Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus -specific Lateral Flow Device test in bronchoalveolar lavage
- (2018) Jeffrey D. Jenks et al. MYCOSES
- Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative
- (2017) Ariya Chindamporn et al. MEDICAL MYCOLOGY
- Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study
- (2017) Martin Hoenigl et al. MYCOSES
- Aspergillus fumigatus morphology and dynamic host interactions
- (2017) Frank L. van de Veerdonk et al. NATURE REVIEWS MICROBIOLOGY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Galactomannan testing andAspergillusPCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis
- (2016) Susanne Eigl et al. MEDICAL MYCOLOGY
- IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
- (2016) Rossana G. Iannitti et al. Nature Communications
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Important drug classes associated with potential drug–drug interactions in critically ill patients: highlights for cardiothoracic intensivists
- (2015) Shadi Baniasadi et al. Annals of Intensive Care
- IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans
- (2014) Antonella de Luca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The clinical spectrum of pulmonary aspergillosis
- (2014) C. Kosmidis et al. THORAX
- Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
- (2013) Martin Hoenigl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4
- (2013) V. O. Millien et al. SCIENCE
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
- (2012) Stijn I. Blot et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
- (2012) Joost Wauters et al. INTENSIVE CARE MEDICINE
- Danger-associated molecular patterns (DAMPs) in acute lung injury
- (2012) Leslie B Tolle et al. JOURNAL OF PATHOLOGY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- DAMP signaling in fungal infections and diseases
- (2012) Cristina Cunha et al. Frontiers in Immunology
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- Genetically-Determined Hyperfunction of the S100B/RAGE Axis Is a Risk Factor for Aspergillosis in Stem Cell Transplant Recipients
- (2011) Cristina Cunha et al. PLoS One
- The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation
- (2011) Guglielmo Sorci et al. PLoS Pathogens
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
- (2008) Timothy Sheahan et al. PLoS Pathogens
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started